Thus, our study demonstrated that the MAPK/ERK pathway activates serine catabolism through phosphorylating and stabilizing SHMT2, contributing to the biosynthesis of macromolecules and functional modification (methylation) for cancer progression. This evidence concerns the gene SHMT2 and cancer.